Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

Crunch Franchise Announces Grand Opening and Ribbon Cutting Ceremony For Crunch Arboretum, Bringing Employment Opportunities To The Local Community


“We are extremely excited about sharing the unique experience of the Crunch brand with the residents surrounding our newest location in Arboretum,” said CR Fitness Holdings CEO Tony Scrimale. “We can’t wait to show you how we combine top-notch equipment, extraordinary classes, and personal training at an unbeatable value.”

Fusing fitness with entertainment, Crunch Arboretum boasts top-quality strength training equipment, an extensive selection of premier cardio equipment, a Group Fitness Studio, HIITZone™, a Cycling Studio, Dry Saunas, HydroMassage®, tanning facilities, and spacious locker rooms, among other amenities.

CR Fitness Holdings is operated by industry veterans Vince Julian, Geoff Dyer, Jeff Dotson, and Tony Scrimale with an impressive combined experience of over 150 years in the fitness sector. Presently, the CR Fitness team operates 55 Crunch Fitness locations spanning Florida, Georgia, North Carolina, and Texas.

Not only will Crunch Arboretum provide world-class fitness equipment and expert trainers, but it will also create new employment opportunities in the local community. We believe in giving back, and Crunch Arboretum will add to our ongoing efforts to support the areas we serve. 

Media Contact

Tricia Mason, CR Fitness, 813 601 7471, [email protected], Crunch.com

SOURCE CR Fitness Holdings

Pioneering a Revolutionary Approach to Mental Health Treatment


Leading with Dedication: Dr. Sandeep Vaishnavi

CNBS is headed by Dr. Sandeep Vaishnavi, MD, PhD, a dedicated clinician with a strong background in Behavioral Neurology & Neuropsychiatry, having completed his fellowship at the well-respected Johns Hopkins University. Dr. Vaishnavi brings to the center a deep understanding of behavioral neurology and neuropsychiatry.

In addition to his medical expertise, Dr. Vaishnavi has penned “The Traumatized Brain”, a comprehensive guide offering insights into brain injuries and their repercussions on mental health. His well-rounded experience and knowledge in the field are anticipated to guide CNBS in offering top-notch, individualized care to its patients.

Welcoming a New Era of Neuropsychiatric Care in North Carolina

Situated at 351 Wellesley Trade Lane, Suite 201, Cary, North Carolina 27519, CNBS is now open and welcoming new patients to their state-of-the-art facility. Individuals seeking revolutionary treatments, underpinned by evidence-based research and carried out by experts in the field, need look no further than CNBS.

“The opening of CNBS not only signifies a new chapter in the advancement of mental health treatments in North Carolina but also serves as a testament to the remarkable strides being made in neuropsychiatry,” states Dr. Vaishnavi. “We are eager to offer our patients a path to recovery that is grounded in innovation and personalized care.”

About the Center for Neuropsychiatry and Brain Stimulation

At CNBS, we are driven by the vision to revolutionize mental health care by leveraging the latest advancements in brain stimulation techniques. Our approach is rooted in a deep understanding of the intricacies of the human brain, coupled with an unwavering commitment to enhancing the well-being of our patients. With an ethos centered on pioneering research and compassionate care, CNBS aims to be the sanctuary where healing and science converge.

For more information or to schedule an appointment, visit https://centerforbrainstim.com/ or call at 919-728-1954.

Media Contact

Alyssa Osman, ARO Effect Marketing, 1 234-719-7970, [email protected], www.aroeffect.com

SOURCE The Center for Neuropsychiatry and Brain Stimulation (CNBS)

Foresee Pharmaceuticals to Present Phase 1/2 Fanconi Anemia Clinical Study Design for its ALDH2 activator FP-045 at the Fanconi Anemia Research Fund 2023 Scientific Symposium


TAIPEI, Taiwan, Sept. 30, 2023 /PRNewswire/ — Foresee Pharmaceuticals (TPEx: 6576), (“Foresee”) announced today that the company will present the clinical design of the FP-045 Phase 1/2 clinical Fanconi anemia clinical study (FuschiA study) currently being initiated, at the Fanconi…